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ABSTRACT
A total of 360 primigravidae were studied at AKTH. 180 each of similar age and socioeconomic status were used 
as cases and controls in a prospective study.
There was no statistically significant difference in their practice of malarial prevention at booking. The 
prevalence of malaria in their blood smears at booking was 32.22%, with the HIV infected cases accounting for 
23.33%, whilst the HIV uninfected accounted for 8.89%The prevalence of clinical malaria was significantly 
eight times higher and the prevalence of recurrent malaria was twenty six times higher in the HIV infected 
primigravidae as compared to the HIV uninfected primigravidae. Review of malarial prophylaxis in HIV infected 
primigravidae is recommended.
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INTRODUCTION
Malaria and Human Immunodeficiency Virus 
(HIV) infection are two of the most common 
1
infections in Sub Saharan Africa, where it is 
estimated that 36.1 million adults and children are 
2
living with HIV/AIDS.  Sub Saharan Africa 
contributes only about 10% of the world's 
population, but account for over 80% of the 
2  
world's HIV infected women. Without 
intervention, it is estimated that about 25 to 45% 
of the HIV infected women will transmit the 
2 infection to their children.   Over 30 million 
women in Africa become pregnant in malaria-
3endemic area each year.  Up to 20% of pregnant 
women in endemic area will have asymptomatic 
4malarial parasitaemia. Even though malaria is a 
curable and preventable disease, it kills over a 
million people a year, majority of whom are 
5
children and pregnant women.  In the tropics, 
Falciparum malaria during pregnancy is a major 
cause of maternal, fetal and neonatal morbidity 
6
and mortality.  It is a major public health issue in 
Africa. The economic cost of Malaria in 
pregnancy and HIV is enormous and weighs 
heavily on the economies of poor African 
7,
countries.
Pregnant women, especially primigravidae and 
secundigravidae are a specific risk group to 
9malaria infection.  HIV infection in pregnancy 
appeared to impair a pregnant woman's ability to 
resist malaria infection. The protection expressed 
by multigravida to malaria infection disappears 
when HIV infection co-exist with malaria. The 
exact mechanism for increased susceptibility to 
malaria during pregnancy is unknown. However, 
it is attributed to suppressed immunity in 
6,10
pregnancy.   It is suggested that the increased 
protein demand in pregnancy is not usually met by 
nutritional supply alone and therefore; protein 
from the immune system is diverted to fill in the 
deficit thereby causing a partial alteration of 
10
immunity. The vast majority of these infections 
are sub-clinical and in most women are 
asymptomatic and therefore undetected and 
untreated. There is specific expression of variants 
of P. falciparum erythrocyte membrane protein-1 
i n  p r e g n a n c y  t h a t  o c c u r s  i n  t h e  
11syncytiotrophoblastic cells . The parasites adhere 
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Table I: Prostaglandin profile of all Respondents
Prostaglandin PGF2á PGE 
Mean± SEM 2.77±0.23 248.79±13.88 
Median 1.98 250.35 
Range 0.15-11.05 21.8-652.0 
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Table II: Prostaglandin profile by semen status, sperm count and socio economic status
PG/Status N Mean± standard 
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to this syncytiotrophoblast more, through this 
protein, leading to intervillous parasitaemia. The 
intervillous parasitaemia causes “leakage” 
through the placental barrier which is thought to 
increase vertical transmission of HIV where the 
infection co-exists with malarial infection. 
However, with subsequent pregnancies, protective 
immune mechanism gradually develops and 
expands, and manifestation of infection declines. 
With the binding of parasites in the intervillous 
spaces, there is placental sequestration, placental 
infiltration by inflammatory cells and release of 
pro-inflammatory mediators. The effects of these 
are maternal anaemia, low birth weight and 
preterm delivery with increased perinatal 
11
mortality .
Some components of immune response to P. 
falciparum are modified by HIV infection. P. 
falciparum stimulates HIV replication by 
increased cytokine production (interleukin 6 and 
tumour necrosis factor alpha) by activated 
lymphocytes. It also increases potential HIV 
reservoir in the placenta by increasing the 
Chemokine receptor 5(CCR 5+) receptors in the 
12placenta . These changes result in HIV positive 
women being more likely to develop malaria in 
pregnancy than seronegative women, and also 
have rapid progression of their HIV infection 
12
during pregnancy .  Dual infection therefore, has 
detrimental effect on maternal and infant survival.
Effective malaria control will reduce the 
prevalence of malaria infection in the community 
and will reduce pregnancy associated malaria 
complications. In addition, there will be a 
reduction in the severity and complications of HIV 
in pregnancy. The huge economic burden saddled 
in the treatment of malaria can be channeled to 
provision of other health and social needs of the 
community that will improve quality of life.
The study was embark upon in order to ascertain 
the Prevalence  of asymptomatic malaria among 
HIV infected  and  HIV uninfected primigravidae 
who registered in AKTH for antenatal care.
MATERIALS AND METHODS
Aminu Kano Teaching Hospital (AKTH) is a 500-
bed hospital established in 1988. It is located in 
Kano, the largest commercial centre of northern 
Nigeria. The hospital receives clients from within 
Kano and the neighboring States of Jigawa, 
Katsina, Kaduna, Bauchi and Zamfara. The 
majority of patients are Hausa or Fulani, although 
substantial numbers are Ibo or Yoruba. Most are 
traders, farmers, businessmen or civil servants. 
The hospital operates a specialist antenatal clinic 
(ANC) four times per week, attending to an 
average of 120 clients per day; The PMTCT 
programme has been fully integrated into the 
hospital's obstetrics services. In the ANC, 
voluntary group counseling is offered to all new 
clients, along with routine HIV testing, with a 
right to 'opt out.' HIV-positive patients are then 
offered full PMTCT services.
Routinely two doses of Sulphadoxine-
R
pyrimethamine combination (Fansidar ) is given 
to the HIV uninfected pregnant women at four 
weeks interval after 18 weeks of gestation, while 
14the HIV infected receives three doses .
All ANC clients are also supplied with ITN and 
are advised to sleep under it and are also advised 
to clear their surroundings of mosquito breeding 
sites.
STUDY DESIGN:
The study was a prospective study conducted 
among pregnant women attending AKTH for 
their antenatal care.
Study Population:
The study population is pregnant women 
attending the ANC clinic of AKTH.
INCLUSION CRITERIA:
Primigravidae who register for ante natal care at 
gestational age of 16 weeks or less during the 
study period, gave their consent to participate in 
the study and consented to HIV screening were 
recruited. Where the patient was not sureof her 
LMP, ultrasound scan dating was employed.
The reason for selection of only primigravidae as 
cases and control is because primigravidae have 
lowered immunity to malaria infection compared 
9
to multigravidae , and this variation in the level of 
immunity may interfere with the outcome of the 
study.
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SAMPLE SIZE DETERMINATION:
The minimum sample size was determined using 
the formula for sample size estimation as follows:
 2 2n=( z +z ) (p q  + p q )/ ( p -p )á â 1 1 2 2 2 1
where; n= minimum sample required,
z  = standard normal deviate at 95%á
Confidence level, =1.96
z standard normal deviate corresponding to the â =
power of the test to detect differences, 95% power 
was used for this study. The value obtained from 
the normal distribution table is 1.64.
p = prevalence of malaria among HIV1
15
Positive pregnant women of 56.3%  =0.56
q = complimentary probability to p  = 1-p  (1-1 1 1
0.56=0.44)
p =prevalence of malaria among HIV negative 2
15pregnant women of 36.5% = 0.37.
q = complimentary probability to p  = 1-p  (1-2 2 2
0.37=0.63)
2Therefore, n= (1.96 + 1.64)  [(0.56x0.44) + 
2(0.37x0.63)] / (0.37-0.56)
Thus; n= 172.The sample was approximated to 
180. 
SAMPLING TECHNIQUE:
For every HIV infected primigravida recruited, 
the next HIV uninfected primigravida of similar 
age and socioeconomic status was recruited as 
control till the total number of 180 was obtained 
in both groups. The socioeconomic status of the 
women was derived from their level of education 
and their husband's occupation. 
INSTRUMENT OF DATA COLLECTION:
A proforma that was designed for this study was 
used to record the data obtained from the patients. 
The proforma had two sections, A and B. Section 
A asked questions on practice of malaria 
prevention of the enrollees while section B was 
the result of laboratory investigation at booking 
and follow up of the patients to detect clinical and 
recurrence of malaria fever. 
Blood samples taken for routine ante natal 
investigations at booking were used for malaria 
parasite determination. Giemsa staining 
technique was used to stain the thin film for 
malaria parasite. Patients that came with features 
of clinical and recurrent malaria had blood smear 
for malaria parasite done to confirm malaria 
infection.
DATA  ANALYSIS: 
Data obtained was entered into a personal 
computer for analysis. Analysis was done using 
Minitab Inc 1998 statistical software. Qualitative 
data was presented as percentages while 
quantitative data was presented as mean and 
standard deviation. A chi square test was used to 
determine significant association between 
qualitative variables. A P- value of 0.05 or less 
was considered significant.
ETHICAL CLEARANCE:
Ethical clearance for the study was obtained from 
the ethical committee of Aminu Kano Teaching 
Hospital
RESULTS:
 A total of 360 primigravidae were recruited for 
the study. Among them 180 were infected while 
180 were uninfected by HIV.
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Table 1. 
Practice of Malarial prevention by HIV 
uninfected and HIV infected Primigravidae 
before booking
A. ITN USE      
VARIABLE YES (%)       NO (%) P-VALUE OR CI 
Uninfected 97(53.89) 83(46.11)  1.00  
Infected 86(47.78) 94(52,22) 0.25 1.28 0.83-1.97  
Total 183(50.83) 177(49.17)    
 
B. USE OF MALARIA 
PROPHYLAXIS 
     
Uninfected 85(47.22) 95(52.78)  1.00  
Infected 96(53.33) 84(46.67) 0.27 0.78 0.51-1.21 
Total 181(50.28) 179(49.72)    
 
C. USE OF INSECTICIDES 
     
Uninfected 98(54.44) 82(45.56)  1.00  
Infected 83(46.11) 97(53.89) 0.11 1.40 0.90-2.16 




     







0.34 1.22 0.79-1.89 
 
Table 2. 
Prevalence of Malaria Parasites in blood 
smears of HIV uninfected and HIV infected 
Primigravidae at booking. 
STATUS  Blood smear    
 Present (%)  Absent (%) P-value OR CI 
Uninfected 16(8.89) 164(91.11)  1.00  
Infected 42(23.33) 132(76.69) 0.0001 3.26 1.62-6.36 
Total 58(16.11) 296(83.89)    
 
Table 4. 
Prevalence of recurrent malaria among HIV 
infected and HIV uninfected Primigravidae.
STATUS  RECURRENCE    
 YES (%)    NO (%) P value OR CI 
Uninfected 1(33.33)    2(66.67)    1.0  
Infected 26(92.86)    2(7.14) 0.037 26.0 1.05-1360 
Total 27(87.07)    4 (12.93)    
 
Table 3. 
Prevalence of clinical Malaria among HIV 
infected and HIV uninfected Primigravidae.
STATUS CLINICAL MALARIA    
 YES (%) NO (%) P-VALUE OR CI 
Uninfected 3(18.75) 13(81.25)  1.00  
Infected 28(66.67) 14(33.33) 0.001 8.67 1.87-46.37 
Total 31(53.45) 27(46.55)    
 
There was no statistically significant difference 
in the practice of malarial prevention between the 
HIV infected and the HIV uninfected 
Primigravidae before booking as shown in table 1 
The prevalence of malaria Parasitaemia was 
23.33% among the HIV infected primigravidae, 
and 8.89% among the HIV uninfected 
primigravidae. The odds of occurrence of malaria 
Parasitaemia among the HIV infected 
primigravidae was three times higher than that 
among the HIV uninfected primigravidae. (OR= 
3.26, CI = 1.62-6.36, p< 0.05) as shown in Table 
2.
Table 3 showed the prevalence of clinical malaria 
was 66.67% among the HIV infected 
primigravidae compared to 18.75% among the 
HIV uninfected primigravidae. The odd of 
occurrence of clinical malaria among the HIV 
infected primigravidae was eight times higher 
than among HIV uninfected primigravidae, 
which is statistically significant.  (OR= 8.67, CI= 
1.87-46.37, p< 0.05) Recurrence of clinical 
malaria occurred in 92.86% of the HIV infected 
primigravidae, while among the HIV uninfected 
primigravidae it was 33.33%.The odd of 
recurrence of clinical malaria was twenty six 
times higher among HIV infected women 
compared to HIV uninfected primigravidae. 
Recurrence of clinical malaria was found to show 
statistically significant difference between HIV 
infected and HIV uninfected primigravidae with 
a P value of 0.037 as shown in Table 4.
DISCUSSION:
The prevalence of malaria Parasitaemia in the 
study population was found to be 32.22%. The 
HIV infected primigravidae accounted for 
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23.33%, while the HIV uninfected primigravidae 
accounted for 8.89%. This finding was similar to 
9,22that from Awka in Nigeria  and from Chikwawa 
15District, Southern Malawi  all of which reported 
high prevalence of malaria parasitaemia among 
primigravidae at booking. The prevalence was 
however lower than that in malaria non-endemic 
16,17regions . This difference could be because of 
partial immunity to malaria in malarial endemic 
areas, which is lowered by HIV infection.  This 
can be appreciated in this review where the 
prevalence of clinical malaria was about eight 
times higher among HIV infected primigravidae 
and the risk of having recurrence of clinical 
malaria was twenty six times higher than among 
HIV uninfected women despite using three doses 
of IPT for HIV infected and two doses for HIV 
uninfected women during their antenatal period. 
This was similar to the finding of other workers 
18,19from malaria endemic regions .
.
The practice of malaria prevention before booking 
among the cases and controls, which did not show 
any statistically significant difference between the 
two groups, was necessary in order to confirm that 
the difference in malarial parasitaemia in their 
blood smears that were taken at booking, which 
was three times higher among the HIV infected 
was not as a result of differences in the practice of 
prevention of malarial infection among the two 
20, 21, 23
groups before booking .
The prevalence of clinical malaria which was 
eight times higher and recurrence of clinical 
malaria which was twenty six times higher among 
the HIV infected women despite three doses of 
IPTp was probably due to their higher 
susceptibility to malarial infection as a result of 
10lowering of their partial immunity . This call for a 
review of their malarial prophylaxis, in order to 
control the high prevalence of malarial 
parasitaemia among them, as it has been found to 
be associated with high feto-maternal morbidity 
13,24and mortality, and failure of PMTCT of HIV .
This study agrees with the recommendation of 
18
other similar studies  that the malarial 
prophylaxis that is given to HIV infected women 
should be increased from three doses to four doses 
to correspond with the WHO recommended four 
antenatal visits in the focused antenatal care in 
order to ensure compliance and to reduce feto-
maternal morbidity and mortality associated with 
malarial infection in pregnancy and also to ensure 
success of prevention of mother to child 
transmission of HIV infection. 
CONCLUSION:
The prevalence of malaria parasitaemia among 
HIV infected primigravidae at booking was found 
to be three times higher than among the HIV 
uninfected primigravidae. Likewise the 
prevalence of clinical malaria and recurrent 
malaria infection was found to also be 
significantly higher in them despite the routine 
antimalarial prophylaxis.
Recommendation:
With the increased risk of clinical and recurrent 
malarial infection in HIV infected primigravidae, 
it is recommended that IPT  should be increased p
from 3 to 4 doses among the HIV infected 
primigravidae. This should correspond with the 
four antenatal visits in the focused antenatal care 
in order to ensure compliance.
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